ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,268,000 | -41.7% | 178,150 | -33.8% | 0.17% | -43.5% |
| Q2 2022 | $2,176,000 | -11.1% | 268,925 | +52.5% | 0.29% | -5.8% |
| Q1 2022 | $2,448,000 | +34.4% | 176,342 | +171.7% | 0.31% | +21.9% |
| Q4 2021 | $1,821,000 | +74.8% | 64,899 | +268.3% | 0.26% | +54.2% |
| Q4 2020 | $1,042,000 | -9.5% | 17,623 | -25.5% | 0.17% | -21.3% |
| Q3 2020 | $1,151,000 | +264.2% | 23,666 | +261.7% | 0.21% | +744.0% |
| Q2 2019 | $316,000 | – | 6,543 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |